SE8702843L - NEW USE OF BROMOCCRIPTIN - Google Patents

NEW USE OF BROMOCCRIPTIN

Info

Publication number
SE8702843L
SE8702843L SE8702843A SE8702843A SE8702843L SE 8702843 L SE8702843 L SE 8702843L SE 8702843 A SE8702843 A SE 8702843A SE 8702843 A SE8702843 A SE 8702843A SE 8702843 L SE8702843 L SE 8702843L
Authority
SE
Sweden
Prior art keywords
bromoccriptin
new use
disease
autoimmune
bromocriptine
Prior art date
Application number
SE8702843A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE8702843D0 (en
Inventor
D Larson
P Hiestand
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8702843D0 publication Critical patent/SE8702843D0/en
Publication of SE8702843L publication Critical patent/SE8702843L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Bromocriptine is used in the treatment of Myasthenia gravis, endocrine opthalmopathy, Grave's disease, Juvenile diabetes, Glomerulonephritis, SLE, Autoimmune hematological disorder, MS and Autoimmune inflammatory bowel disease.
SE8702843A 1986-07-14 1987-07-13 NEW USE OF BROMOCCRIPTIN SE8702843L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88511086A 1986-07-14 1986-07-14

Publications (2)

Publication Number Publication Date
SE8702843D0 SE8702843D0 (en) 1987-07-13
SE8702843L true SE8702843L (en) 1988-01-15

Family

ID=25386156

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702843A SE8702843L (en) 1986-07-14 1987-07-13 NEW USE OF BROMOCCRIPTIN

Country Status (13)

Country Link
JP (1) JPS6323817A (en)
KR (1) KR880001292A (en)
AU (1) AU602154B2 (en)
CH (1) CH672987A5 (en)
DE (1) DE3722383A1 (en)
DK (1) DK363887A (en)
FR (1) FR2601245A1 (en)
GB (1) GB2192541B (en)
IT (1) IT1224222B (en)
NL (1) NL8701631A (en)
PH (1) PH24525A (en)
SE (1) SE8702843L (en)
ZA (1) ZA875145B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814521A1 (en) * 1987-05-07 1988-11-17 Sandoz Ag NEW APPLICATION OF DOPAMINE RECEPTOR AGONISTS
EP0327040A3 (en) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Use of dopamine and/or dopamine agonists to prepare a medicine for the treatment of the digestive tract
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US5830895A (en) * 1988-05-10 1998-11-03 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for the determination and adjustment of prolactin daily rhythms
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5716932A (en) * 1988-05-10 1998-02-10 Louisiana State University And Agricultural And Mechanical College Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
HUT67688A (en) * 1991-12-23 1995-04-28 Univ Louisiana State Preparations for treating pathologies of type ii
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5714519A (en) * 1995-06-07 1998-02-03 Ergo Science Incorporated Method for regulating glucose metabolism
US5626860A (en) * 1995-06-07 1997-05-06 The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
US20090325997A1 (en) * 2006-11-23 2009-12-31 Ergonex Pharma Gmbh Pharmaceutical Compositions For The Treatment Of Capillary Arteriopathy
DK3445362T3 (en) * 2016-04-20 2021-10-11 Veroscience Llc Composition and method of treatment of metabolic diseases
JP7231255B2 (en) 2017-10-18 2023-03-01 ヴェロサイエンス,リミテッド・ライアビリティー・カンパニー Improved bromocriptine formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (en) * 1968-05-31 1971-05-15 Sandoz Ag Process for the preparation of 2-bromo-a-ergocryptine
CH666406A5 (en) * 1984-02-29 1988-07-29 Sandoz Ag METHOD FOR PRODUCING microcapsules BROMOKRIPTINMESYLAT AS PHARMACOLOGICAL ACTIVE INCLUDED.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions

Also Published As

Publication number Publication date
PH24525A (en) 1990-07-18
CH672987A5 (en) 1990-01-31
SE8702843D0 (en) 1987-07-13
DK363887D0 (en) 1987-07-13
GB2192541A (en) 1988-01-20
DK363887A (en) 1988-01-15
KR880001292A (en) 1988-04-22
AU7558787A (en) 1988-01-21
ZA875145B (en) 1989-02-22
NL8701631A (en) 1988-02-01
FR2601245A1 (en) 1988-01-15
AU602154B2 (en) 1990-10-04
JPS6323817A (en) 1988-02-01
IT8748160A0 (en) 1987-07-10
GB8716323D0 (en) 1987-08-19
GB2192541B (en) 1990-05-02
DE3722383A1 (en) 1988-01-28
IT1224222B (en) 1990-09-26

Similar Documents

Publication Publication Date Title
SE8702843L (en) NEW USE OF BROMOCCRIPTIN
FR2543959B1 (en) COPOLYMER SUITABLE FOR THE PREPARATION OF SOFT CONTACT LENSES AND CONTAINING WATER
NO873351D0 (en) HAIR CLEANER MIXTURE AND USE OF THIS.
DK440786D0 (en) INSECTICID PREPARATION, INCLUDING SYNTHETIC PYRETHROIDS AND DISSERTATION AND USE OF THE PREPARATION
OA09362A (en) "Production and use of porphyrins".
IT1227064B (en) FLUORINATED POLYURETHANE, CONTAINING POLYOXYPERFLUOROALKYLENE BLOCKS WITH IMPROVED MECHANICAL PROPERTIES
ES1000941Y (en) KEY RING WITH REMOVABLE PEN
DE3270334D1 (en) Organic peroxides and use of same
GB8621932D0 (en) Speech coding
GB8616696D0 (en) Kit of parts
GB8611205D0 (en) Determination of antigen
NO844722L (en) OLEPHINE SULPHONATE MIXTURE, AND USE OF THIS
AU8192987A (en) Human ldh-c4 cdna sequences encoding antigenic regions
ES2015961B3 (en) PLUG WITH SLIDING LOCK
ZA872754B (en) Electrochemical reduction of iodopolyfluoroalkanes and fluorinated compounds thereby obtained
GB8616228D0 (en) Forming ring body of bearing
GB8706726D0 (en) Determination of water
SE8705060D0 (en) ANTI-COOLING KIT, ANTI-COOLING PREPARATION AND USE OF IT
GB8700776D0 (en) Disabled person's aid
KR870015953U (en) Key ring with compass
KR880001267A (en) Bath back
ZA873391B (en) Chlorination of water
FR2595428B1 (en) WATERTIGHT RING
Willis Dreams of Darkness: Fantasy and the Films of Val Lewton
AU7985687A (en) Manual interface combined with the use of electronic digital character coding system

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8702843-7

Effective date: 19920201

Format of ref document f/p: F